As announced, Evonik has doubled its capacity for transparent, high-performance polyamide TROGAMID® CX in Marl. The planned expansion went on stream as scheduled in February 2020.
 |
|
TROGAMID® CX results in high-quality surfaces that show no traces of daily wear and tear. |
“The reason we created the additional production capacity was because demand for TROGAMID® CX keeps growing. Now we can continue serving and supporting our customers’ growth just as before," says Viviane Papa, who heads up the Granules & Compounds product line at Evonik, explaining the rationale behind the investment.
Proven chemical resistance and lasting transparency
Always perfectly clear, polyamide is semi-crystalline, which makes it more resistant to chemicals and stress cracks than transparent, amorphous plastics.
The compound is also highly resistant to UV radiation, absorbs little water, exhibits high dimensional stability, and blends quality and design freedom with superior processing characteristics. This unique combination of properties makes TROGAMID® CX molding compounds suitable for use in a wide range of applications, such as water management, filter technology, laboratory and medical engineering, and the production of containers for the cosmetics industry. In addition to the design freedom it offers, designers of sports and ski goggles also prize the material’s mechanical strength and resistance to chemical substances found in products such as skin creams or hair sprays. This stability—verified for the decorative material in what is known as the sunscreen test—as well as its considerable scratch resistance are also properties required for vehicle interior components.
Abiut Evonik
Evonik is one of the world leaders in specialty chemicals. The focus on more specialty businesses, customer-oriented innovative prowess and a trustful and performance-oriented corporate culture form the heart of Evonik’s corporate strategy. They are the lever for profitable growth and a sustained increase in the value of the company. Evonik benefits specifically from its customer proximity and leading market positions. Evonik is active in over 100 countries around the world. In fiscal 2018, the enterprise with more than 32,000 employees generated sales of €13.3 billion and an operating profit (adjusted EBITDA) of €2.15 billion from continuing operations.
